Print

Genmab A/S (GEN.CO), GlaxoSmithKline (GSK) (JOBS) Cancer Drug Arzerra Disappoints in Phase 3 Study  
8/18/2009 6:42:18 AM

Bookmark and Share

Reuters -- Disappointing clinical results sent shares in Danish biotechnology company Genmab tumbling 26 percent on Tuesday as investors questioned sales prospects for its key drug Arzerra in treating blood cancer.

//-->